Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jul 15, 2019; 11(7): 551-566
Published online Jul 15, 2019. doi: 10.4251/wjgo.v11.i7.551
Published online Jul 15, 2019. doi: 10.4251/wjgo.v11.i7.551
Figure 2 Kaplan-Meier survival curve for overall survival according to BRAF mutation status (V600E vs WT - wild type).
aP < 0.05.
- Citation: Ntavatzikos A, Spathis A, Patapis P, Machairas N, Vourli G, Peros G, Papadopoulos I, Panayiotides I, Koumarianou A. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World J Gastrointest Oncol 2019; 11(7): 551-566
- URL: https://www.wjgnet.com/1948-5204/full/v11/i7/551.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i7.551